Oncology Hematology West, PC dba Nebraska Cancer Specialists — Omaha, Nebraska

Oncology Hematology West, PC dba Nebraska Cancer Specialists is a clinical research site located in Omaha, Nebraska, United States 68114.

Crixeo Health Trust Score: 82/100 (GOOD). This profile has not yet been claimed by the site owner.

Oncology Hematology West, PC dba Nebraska Cancer Specialists has participated in 24 clinical trials with 10 currently active.

Therapeutic areas: HER2-positive Breast Cancer, HER2 Positive Breast Cancer, Metastasis From Malignant Tumor of Prostate.

Sponsors: Seagen, a wholly owned subsidiary of Pfizer, Curium US LLC, ImmunoVaccine Technologies, Inc. (IMV Inc.).

Sponsor Feasibility Report

Trust Score: 82/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Oncology Hematology West, PC dba Nebraska Cancer Specialists?

Oncology Hematology West, PC dba Nebraska Cancer Specialists has a Crixeo Trust Score of 82/100 (GOOD). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Oncology Hematology West, PC dba Nebraska Cancer Specialists conducted?

Oncology Hematology West, PC dba Nebraska Cancer Specialists has 24 clinical trials on record, with 10 currently active. Their work covers HER2-positive Breast Cancer, HER2 Positive Breast Cancer, Metastasis From Malignant Tumor of Prostate.

Is Oncology Hematology West, PC dba Nebraska Cancer Specialists accredited by Crixeo Health?

Yes — Oncology Hematology West, PC dba Nebraska Cancer Specialists holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.

Can I submit a review or complaint about Oncology Hematology West, PC dba Nebraska Cancer Specialists?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.